Durable Long-Term Responses in Patients with Myelodysplastic Syndromes Treated with Lenalidomide-Reference-Cited by-同舟云学术

Durable Long-Term Responses in Patients with Myelodysplastic Syndromes Treated with Lenalidomide

Published:2009-06 Issue:3 Volume:9 Page:E10-E13
ISSN:1557-9190
Container-title:Clinical Lymphoma and Myeloma
language:en
Short-container-title:Clinical Lymphoma and Myeloma

Author:

Kurtin Sandra E.,List Alan F.

Publisher

Elsevier BV

Subject

Cancer Research,Oncology,Hematology,General Medicine

Reference9 articles.

1. Report of an international working group to standardize response criteria for myelodysplastic syndromes;Cheson;Blood,2000

2. Time-dependent prognostic scoring system for predicting survival and leukemia evolution in myelodysplastic syndromes;Malcovati;J Clin Oncol,2007

3. A validated decision model for treating the anaemia of myelodysplastic syndromes with erythropoietin + granulocyte colony-stimulating factor: significant effects on quality of life;Hellström-Lindberg;Br J Haematol,2003

4. Identification of novel cytogenetic markers with prognostic significance in a series of 968 patients with primary myelodysplastic syndromes;Solé;Haematologica,2005

5. New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients;Haase;Blood,2007

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activity of a Novel Anti-Inflammatory Agent F-3,6′-dithiopomalidomide as a Treatment for Traumatic Brain Injury;Biomedicines;2022-09-30

2. Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments;Frontiers in Cell and Developmental Biology;2019-12-04

3. Treatment of Lymphoid and Myeloid Malignancies by Immunomodulatory Drugs;Cardiovascular & Hematological Disorders-Drug Targets;2019-01-28

4. Novel Molecular Mechanism of Regulation of CD40 Ligand by the Transcription Factor GLI2;The Journal of Immunology;2017-05-01

5. 8-year-sustained response in a patient with isolated del(5q) myelodysplastic syndrome undergoing continuous treatment with lenalidomide: a case report;memo - Magazine of European Medical Oncology;2015-12-08